pocketful logo light
pocketful logo light
Jagsonpal Pharmaceuticals Ltd logo

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM BSE: 507789

212.28

(0.82%)

Tue, 23 Jun 2026, 01:18 am

Jagsonpal Pharmaceuticals Share Price Live Chart

1 Day

(0.82%)

No Result Found

Summary

  • Market Cap (in Cr)

    1352.73

  • Net Profit (in Cr)

    55.36

  • P/B

    5.99

  • Sector P/E

    44.89

  • P/E

    25.89

  • EV/EBITDA

    16.65

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    18.58

  • ROCE

    22.82

  • Debt/Equity

    0.04

  • EPS (TTM)

    6.81

  • Dividend Yield

    1.98

  • Book Value

    42.10

  • Interest Cover

    53.26

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters67.8967.3967.5467.6567.78
FII2.442.122.122.182.10
DII0.220.150.090.050.00
Public29.4530.3430.2530.1230.11
Government00000

Read More

Technical Analysis

RSI

68.73

MACD

3.02

50 DMA

204.88

200 DMA

201.64

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic269.80239.29222.94208.78192.43178.27147.76
Fibonacci239.29227.63220.43208.78197.12189.92178.27
Camarilla214.99212.19209.40208.78203.80201.01198.21

Pivots Level: Classic

R3

+61.02

269.80

R2

+30.51

239.29

R1

+14.17

222.94

208.78
208.78
Pivot Point
LTP: 222.71

S1

-16.34

192.43

S2

-30.51

178.27

S3

-61.02

147.76

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    211.48

  • 20-EMA

    208.80

  • 30-EMA

    206.98

  • 50-EMA

    203.53

  • 100-EMA

    199.72

  • 200-EMA

    202.07

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
27 Apr 2026board-meetingsAccounts, Final Dividend
12 Mar 2026buyback
21 Jan 2026board-meetingsQuarterly Results
03 Nov 2025board-meetingsQuarterly Results
12 Aug 2025dividendFinal Dividend - Rs. - 2.512 Sept 2025
26 Jul 2025agm
06 May 2025dividend₹2.50 Dividend /Share12 Sept 2025
08 Dec 2024dividendFace Value Split (Sub-Division) - From Rs 5/- Per Share To Rs 2/- Per Share08 Jan 2025
08 Dec 2024splitStock Split From Rs.5 to Rs.208 Jan 2025
23 Oct 2024split1:2.5 Splits of Equity Shares08 Jan 2025

Read More

Peer Comparison

Jagsonpal Pharmaceuticals Ltd logo

Jagsonpal Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Jagsonpal Pharmaceuticals Ltd About

Jagsonpal Pharmaceuticals engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1978

Headquarters

CEO

Harsha Raghavan

Employees

Contact

Website icon

Website

http://www.jagsonpal.com

Email icon

Email

skmata@jagsonpal.com; cs@jagsonpal.com

Phone icon

Phone

91-011-46181100/46109900

Location icon

Location

T-210 J, Shahpur Jat, New Delhi, New Delhi, 110049

Read More

Jagsonpal Pharmaceuticals Ltd Company History

YearHistory
No Result Found

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
HRTI PRIVATE LIMITEDbulkSell343628293.528 Jul 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy498300293.6828 Jul 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell498300294.128 Jul 2025
HRTI PRIVATE LIMITEDbulkBuy350647293.5628 Jul 2025
ANKITA VISHAL SHAHbulkSell154425779.5429 Nov 2024
ANKITA VISHAL SHAHbulkBuy249425775.1729 Nov 2024
INFINITY PORTFOLIO HOLDINGSblockBuy220000040013 Sept 2024
INFINITY PORTFOLIO HOLDINGSbulkBuy220000040013 Sept 2024
INFINITY HOLDINGSblockSell220000040013 Sept 2024
INFINITY HOLDINGSbulkSell220000040013 Sept 2024

Read More

Jagsonpal Pharmaceuticals Ltd News

Infinity Holdings confirms no share encumbrance in FY26

Infinity Holdings disclosed no encumbrance of shares in Jagsonpal Pharmaceuticals Limited for FY26. The declaration was made under SEBI Regulation 31(4).

03 Jun 2026

companies

Jagsonpal completes 16 lakh share buyback

Jagsonpal Pharmaceuticals extinguished 16,00,000 equity shares on June 02, 2026. The buyback reduced share capital to ₹13,10,78,300.

02 Jun 2026

companies

Jagsonpal Buyback Concludes

Jagsonpal Pharmaceuticals concluded its ₹40 crore buyback, accepting 16 lakh shares at ₹250 each. The offer was subscribed 3.67 times.

25 May 2026

companies

Jagsonpal Pharma Independent Director Resigns

Mrs. Pallavi Dinodia Gupta resigns as Independent Director of Jagsonpal Pharmaceuticals, effective May 18, 2026, citing personal and professional reasons.

18 May 2026

companies

Jagsonpal Pharma Buyback Opens May 8, Closes May 14

Jagsonpal Pharmaceuticals launches equity buyback from May 08 to May 14, 2026, with small shareholders entitled to 47 shares for every 637 held on the May 04 record date.

08 May 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number